Send to

Choose Destination
  • PMID: 27600072 was deleted because it is a duplicate of PMID: 26998349
Microarrays (Basel). 2016 Mar;5(1). pii: 6. Epub 2016 Mar 7.

Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders.

Author information

Functional Genomics Laboratory, Department of Psychiatry & Human Behavior, University of California, Irvine, CA 92697; Department of Psychiatry & Human Behavior, University of California, Irvine, CA 92697, USA.
Department of Psychiatry, University of California, San Francisco, CA 94103, USA.
VA Boston Healthcare System, Brockton, MA 02301, USA; Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA.
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94304, USA.
Department of Psychiatry, Cornell University of California, Ithaca, NJ 10065, USA.
HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USA.
The Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, MI 48109, USA.
Department of Psychiatry & Human Behavior, University of California, Irvine, CA 92697, USA.


Genome-wide association studies of schizophrenia encompassing the major histocompatibility locus (MHC) were highly significant following genome-wide correction. This broad region implicates many genes including the MHC complex class II. Within this interval we examined the expression of two MHC II genes (HLA-DPA1 and HLA-DRB1) in brain from individual subjects with schizophrenia (SZ), bipolar disorder (BD), major depressive disorder (MDD), and controls by differential gene expression methods. A third MHC II mRNA, CD74, was studied outside of the MHC II locus, as it interacts within the same immune complex. Exon microarrays were performed in anterior cingulate cortex (ACC) in BD compared to controls, and both HLA-DPA1 and CD74 were decreased in expression in BD. The expression of HLA-DPA1 and CD74 were both reduced in hippocampus, amygdala, and dorsolateral prefrontal cortex regions in SZ and BD compared to controls by specific qPCR assay. We found several novel HLA-DPA1 mRNA variants spanning HLA-DPA1 exons 2-3-4 as suggested by exon microarrays. The intronic rs9277341 SNP was a significant cis expression quantitative trait locus (eQTL) that was associated with the total expression of HLA-DPA1 in five brain regions. A biomarker study of MHC II mRNAs was conducted in SZ, BD, MDD, and control lymphoblastic cell lines (LCL) by qPCR assay of 87 subjects. There was significantly decreased expression of HLA-DPA1 and CD74 in BD, and trends for reductions in SZ in LCLs. The discovery of multiple splicing variants in brain for HLA-DPA1 is important as the HLA-DPA1 gene is highly conserved, there are no reported splicing variants, and the functions in brain are unknown. Future work on the function and localization of MHC Class II proteins in brain will help to understand the role of alterations in neuropsychiatric disorders. The HLA-DPA1 eQTL is located within a large linkage disequilibrium block that has an irrefutable association with schizophrenia. Future tests in a larger cohort are needed to determine the significance of this eQTL association with schizophrenia. Our findings support the long-held hypothesis that alterations in immune function are associated with the pathophysiology of psychiatric disorders.


alternative splicing; exon array; expression quantitative trait locus; major histocompatibility locus II


Supplemental Content

Loading ...
Support Center